Molecular Mechanisms of Intervention With Lishukang Capsule in a Rat Model of High-Altitude Pulmonary Edema
Abstract
Objective
To investigate the molecular targets and signaling pathways involved in the therapeutic effects of Lishukang Capsule (LSK) in a rat model of high-altitude pulmonary edema (HAPE) using a proteomics-based approach.
Methods
A total of 60 male Wistar rats were randomly assigned to a control group, a HAPE model group, 3 LSK treatment groups receiving low-, medium-, and high-dose LSK, respectively, and a Rhodiola rosea (also known as Hongjitian [HJT] in pinyin, a Chinese Romanization system) control group. After HAPE modeling, the pharmacodynamic effects were assessed and the optimal LSK dose was determined using HE stains, inflammatory cytokine quantification, lung tissue water content, and the protein concentration in bronchoalveolar lavage. Label free quantitative proteomic profiling was then applied to identify differentially expressed proteins (DEPs) in the optimal dose group, using a screening threshold of over 1.5-fold change and P < 0.05. The selected DEPs were validated with Western blotting, followed by Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
Results
The medium-dose LSK group exhibited significant anti-HAPE effects. Findings from the proteomic analysis revealed, in the comparison with the control group, 267 DEPs were identified in the HAPE group. In the comparison with the HAPE group, 225 DEPs were identified in the medium-dose LSK group. A total of 112 DEPs in the control group were normalized following LSK treatment in the medium-dose LSK group. In addition, GO enrichment analysis of proteins differentially expressed between the HAPE and LSK group showed that these DEPs were mainly enriched in 12 biological processes, 2 cellular components, and 5 molecular functions. KEGG pathway analysis showed that LSK activated pathways associated with cell adhesion molecules, glycosaminoglycan biosynthesis, DNA replication/nucleotide excision repair, transcriptional dysregulation in cancer, and Herpes simplex virus type 1 (HSV-1) infection, while inhibiting pathways associated with glycerophospholipid metabolism. Some differentially expressed proteins with potential functions were verified by Western blotting, including AGPAT5, NCAM1, SRSF3, and PLA2. These differentially expressed proteins were significantly expressed in the normal group, HAPE group, and LSK group, and the validation results were consistent with proteomic findings, indicating the high reliability of the proteomic results.
Conclusion
LSK exerts a significant protective effect against HAPE. Proteomic analysis suggests that its therapeutic action may be mediated through activating pathways involved in cell adhesion molecules, glycosaminoglycan biosynthesis, DNA replication/nucleotide excision repair, transcriptional dysregulation in cancer, and HSV-1 infection, alongside inhibition of pathways associated with glycerophospholipid metabolism. The key DEPs identified in these pathways may play crucial roles in the preventive and therapeutic effects of LSK on HAPE.
Keywords: High altitude pulmonary edema, Lishukang capsule, Hypobaric hypoxia, Proteomics, LC-MS/MS
Full Text:
PDFReferences
EICHSTAEDT C A, BENJAMIN N, GRÜNIG E. Genetics of pulmonary hypertension and high-altitude pulmonary edema. J Appl Physiol (1985), 2020, 128(5): 1432-1438. doi: 10.1152/japplphysiol.00113.2020.
TETZLAFF K, SWENSON E R, BÄRTSCH P. An update on environment-induced pulmonary edema--"when the lungs leak under water and in thin air". Front Physiol, 2022, 13: 1007316. doi: 10.3389/fphys.2022.1007316.
El ALAM S, PENA E, AGUILERA D, et al. Inflammation in pulmonary hypertension and edema induced by hypobaric hypoxia exposure. Int J Mol Sci, 2022, 23(20): 12656. doi: 10.3390/ijms232012656.
ZUBIETA-CALLEJA G, ZUBIETA-DEURIOSTE N. The oxygen transport triad in high-altitude pulmonary edema: a perspective from the high andes. Int J Environ Res Public Health, 2021, 18(14): 7619. doi: 10. 3390/ijerph18147619.
MENG P P, GUO J K, WANG R, et al. Protective effect of Lishukang capsule on lung tissue damage of rats exposed to simulated high-altitude hypoxia. Med Pharm J Chin PLA, 2020, 32(5): 9-13. doi: 10.3969/j.issn. 2095-140X.2020.05.003.
ZHANG S, WANG N, MA H, et al. A stable rat model of high altitude pulmonary edema established by hypobaric hypoxia combined diurnal temperature fluctuation and exercise. Biochem Biophys Res Commun, 2025, 744: 151193. doi: 10.1016/j.bbrc.2024.151193.
TIAN D D, HAO S J, GENG X L. Research progress in the effect of anti-high altitude plateau pulmonary edema of rhodiola capsules. Chin Pharm, 2015, 18(1): 133-136.
SUN Y M, QIN N N, JI Q, et al. Targets and molecular mechanisms of salidroside in improving high-altitude cognitive function. J Sichuan Univ (Med Sci), 2025, 56(1): 112-119. doi: 10.12182/20250160603.
WANG M, XIE T, WU Y, et al. Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis. Oncol Lett, 2018, 16(4): 4201-4210. doi: 10.3892/ol.2018.9221.
ALAM H, LI N, DHAR S S, et al. HP1γ promotes lung adenocarcinoma by downregulating the transcription-repressive regulators NCOR2 and ZBTB7A. Cancer Res, 2018, 78(14): 3834-3848. doi: 10.1158/0008-5472. CAN-17-3571.
SHI M, NAN X R, LIU B Q. The multifaceted role of FUT8 in tumorigenesis: from pathways to potential clinical applications. Int J Mol Sci, 2024, 25(2): 1068. doi: 10.3390/ijms25021068.
YANG J, GRIFFITHS M, NIES M K, et al. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival. BMC Medicine, 2020, 18(1): 268. doi: 10.1186/s12916-020-01734-3.
SONG Y, DU J, LU P, et al. LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins. Ann Transl Med, 2021, 9(21): 1621. doi: 10.21037/atm-21-4995.
WANG Q, YANG J X, LIU G Q, et al. Research progress of Tibetan medicine on cerebral ischemic diseases. J Pharmal Res, 202140 (2): 97-102. doi: 10.13506/j.cnki.jpr.2021.02.008.
ULM C, SAFFARZADEH M, MAHAVADI P, et al. Soluble polysialylated NCAM: a novel player of the innate immune system in the lung. Cell Mol Life Sci, 2013, 70(19): 3695-3708. doi: 10.1007/s00018-013-1342-0.
MILILLO M A, TROTTA A, SERAFINO A, et al. Bacterial RNA contributes to the down-modulation of MHC-Ⅱ expression on monocytes/macrophages diminishing CD4+ T cell responses. Front Immunol, 2019, 10: 2181. doi: 10.3389/fimmu.2019.02181.
DAI K Z, RYAN J C, NAPER C, et al. Identification of MHC class Ⅰb ligands for stimulatory and inhibitory Ly49 receptors and induction of potent NK cell alloresponses in rats. J Immunol, 2018, 200(8): 2847-2859. doi: 10.4049/jimmunol.1701464.
LUO J P, LIU W X, ZHOU M, et al. Research progress on chemical constituents and biological activities of traditional Tibetan herbal medicine Dracocephalum tanguticum. J Yunnan Minzu Univ(Nat Sci Edi), 2021, 30(4): 305-310. doi: 10.3969 / j.issn.1672-8513.2021.04.001.
现代肿瘤医学, 2023, 31(4): 625-631. doi: 10. 3969/ j.issn.1672-4992.2023.04.006.
YANG Q, MING Y J, WANG X J, et al . Salidroside suppresses proliferation and migration of non-small cell lung cancer cells via miRNA-210-sp/E2F3. Modern Oncology, 2023, 31(4): 625-631. doi: 10. 3969/ j.issn.1672-4992.2023.04.006.
LINGELEM A B D, KAVALIAUSKIENE S, HALSNE R, et al. Diacylglycerol kinase and phospholipase D inhibitors alter the cellular lipidome and endosomal sorting towards the Golgi apparatus. Cell Mol Life Sci, 2021, 78(3): 985-1009. doi: 10.1007/s00018-020-03551-6.
KARAGIOTA A, CHACHAMI G, PARASKEVA E. Lipid metabolism in cancer: the role of acylglycerolphosphate acyltransferases (AGPATs). Cancers (Basel), 2022, 14(1): 228. doi: 10.3390/cancers14010228.
LIU P, CAI H B, LIU Z Y, et al. Effect ofrhodiola on serum SOD, MDA, OX-LDL and MMP-2 levels in patients with acute cerebral infarctioninplateau areas. Chin J Gen Prac, 2016, 14(2): 176-178. doi: 10. 16766/j.cnki.issn.1674-4152.2016.02.003.
Refbacks
- There are currently no refbacks.
